Shareholders Foundation, Inc.

Investigation for Investors in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Announced

An investigation for investors in NASDAQ:ACHN shares over potential securities laws violations by Achillion Pharmaceuticals was announced and NASDAQ:ACHN stockholders should contact the Shareholders Foundation.

 

San Diego, CA -- (SBWIRE) -- 11/28/2016 -- An investigation on behalf of investors of Achillion Pharmaceuticals, Inc. was announced over potential securities laws violations by Achillion Pharmaceuticals in connection certain financial statements.

Investors who purchased shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) concerning whether a series of statements by Achillion Pharmaceuticals regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reachd in early 2015 as high as $15.99 per share. Since then shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) lost substantial value. In fact, shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) declined to as low as $3.78 per share on November 3, 2016 when Achillion Pharmaceuticals, Inc reported its Third Quarter 2016 Financial results and provided an update on its clinical programs.

On November 23, 2016, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares closed at $4.55 per share.

Those who purchased shares of Achillion Pharmaceuticals, Inc. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com